Clinical trials have demonstrated average weight loss of 1215% over 68 weeks with semaglutide 2.4 mg weekly
Jahan, M
Taken as a once-weekly injection, it can make it easier to eat less without feeling deprived
Weeks 12 to 24 Weight loss continues but the rate slows slightly as the body adapts
Important safety considerations for transdermal patches: Avoid applying external heat (such as heating pads, hot water bottles, electric blankets, or prolonged sun exposure) to the patch area, as this may increase drug absorption and side effects Do not cut patches or apply additional adhesives unless specifically instructed to do so Wash hands thoroughly after handling patches to avoid transferring medication to eyes or mucous membranes For patients currently using licensed injectable GLP-1 receptor agonists, continue to follow the administration instructions provided in the PIL and by your healthcare team
I was thinking about what my next meal was going to be, and the second I was eating, I was thinking about what my next meal was going to be on top of that," she said